We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cytomyx Hldgs | LSE:CYX | London | Ordinary Share | GB0033942276 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.10 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2005 10:12 | Still being offered 11.75 | r33skyline | |
04/8/2005 10:10 | 50 k gone through ! | pblack | |
04/8/2005 10:10 | Got 34k at 12.75:0) | snap23 | |
04/8/2005 10:04 | l bought some at 12.7 | wizzbizz | |
04/8/2005 10:01 | Just got 10k at 12.87 no spare funds at all thats all I could muster up. Missed 11p trying to scrounge around to raise £1200 ! | gaybriefs | |
04/8/2005 09:58 | Hi germany up 19% Actuell 0,170 = 12 Pence Time 04.08.05 10:44:18 % change +19,72% Volume 28.580 | pblack | |
04/8/2005 09:55 | Thanks r33 | sarbannesoxley | |
04/8/2005 09:51 | nelson they are 11.75 | r33skyline | |
04/8/2005 09:50 | Might make a phonecall and get a few. I'm looking to cash in on CCO and MDY first though. | sarbannesoxley | |
04/8/2005 09:45 | The offer price shows 13p and the other trades went through at 12.7 but I only paid 11.7 about half an hour ago, don't understand that, not that I'm comlaining mind! | nelson01 | |
04/8/2005 09:42 | You're safe for a 40% return next week nelson. Massive buy order in place, hence the lifting of the price to put off buyers. Once the aforementioned order is filled then boom. | sarbannesoxley | |
04/8/2005 09:38 | Just got in too, mine not show up either! | nelson01 | |
04/8/2005 09:27 | Rampers are in town :-) They're just skint though :-( Anyway, you're looking good for a three or four day rise to 18p at least so keep the faith brothers and sisters. | sarbannesoxley | |
04/8/2005 09:27 | just got in with a small punt 10000 @ 12.7p not showing yet. good luck all. | heliweli | |
04/8/2005 09:21 | got to agree with you Wiz, have been sitting on these for a while, didn't think they would come good ever! Prefer to have a small rise though otherwise the rampers will be in town. | gazza5 | |
04/8/2005 09:16 | these are heading back up big time, get n now because these will be traded big time when word gets out | wizzbizz | |
04/8/2005 09:14 | Chart-wise it looks like you're going to get a sharp return to the 16/18p range, probably today. I'd then see this going to 20p within a week. Good luck to holders old and new. | sarbannesoxley | |
04/8/2005 09:13 | I can't even believe I have no funds to get in here. I guess I'll just have to feel good about discovering it for others. :-) | sarbannesoxley | |
04/8/2005 09:04 | Partnership with Major Pharma RNS Number:7070P Cytomyx Holdings PLC 04 August 2005 For Immediate Release 4 August 2005 Cytomyx further expands ion channel cell line capabilities with a worldwide co-exclusive license agreement with Wyeth Pharmaceuticals Validated Ion Channel cell lines for Kv4.3 and the four KChIP accessory sub-unit proteins are now available from Cytomyx Cytomyx Ltd (Cambridge, UK), a division of Cytomyx Holdings, PLC (AIM:CYX.L), a leading provider of drug discovery products and services, is pleased to announce that it has signed a worldwide co-exclusive license agreement with Wyeth Pharmaceuticals (PA, USA) which allows Cytomyx to create and market cell lines expressing the ion channel, Kv4.3 , and the four KChIP accessory sub-units as research reagents for use in drug discovery and safety pharmacology screening. Wyeth holds the patents and patent applications relating to the ion channels Kv4.3, and the four KChIP accessory sub-units. The validated cell lines can also be accessed via Cytomyx' unique IonScreenTM, Ion Channel Screening Service. The service combines Cytomyx' unparalleled range of validated ion channel cell lines with its expertise in automated electrophysiology to deliver timely, high quality data. This strategically important agreement expands further the unique ion channel cell line and screening service portfolio offered by Cytomyx to pharmaceutical and biotechnology clients worldwide. Currently the company has 18 validated ion channel cell lines available and 50 more are in development. Cytomyx continues to be the industry leader for ion channel related products and services and has seven out of the top ten pharmaceutical companies as clients to date. Kv4.3 and the four KChiP accessory sub-units are important targets for drug discovery and safety pharmacology because they combine in different ways in different tissues to make a significant contribution to regulating the electrical activity of the brain and the heart. This regulation can be disturbed by diseases, is at the core of learning and memory and can be the cause of the side effects of medicines. In consideration of the license Wyeth Pharmaceuticals will access know-how and validated cell lines from Cytomyx, enabling them to progress internal drug screening and safety pharmacology programs. | sarbannesoxley | |
04/8/2005 08:22 | I am a holder too, but a bit fed up with the declining share price. Perhaps today the corner has been turned, though no £ have been announced. | jimmy cricket | |
02/8/2005 08:56 | Very quiet on this bb. Am I the only shareholder? Seems to me the Coy is slowly and undramaticaly building. Long term investment methinks. Any comments if there is another shareholder out there. | dayer | |
22/3/2005 08:20 | Ive sold out didnt think the sale of cytocell was very positive for a company of this size. | gaybriefs | |
22/3/2005 04:06 | Why the sudden move? MM Boredom? | dunskey | |
02/3/2005 17:57 | Ant15 - thanks for the reply. Did you manage to find any more out? Regarding CYX it is good to see it holding its rises and moving further North. I was a bit surprised to see the positive movement with respect to the Cytocell sale though. I guess the market (which knows a lot more than me!) liked it though! | bernieboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions